Medical Management & Therapeutic Drug Monitoring
Sushila Dalal, MD
2025 IBD Pharmacist Virtual Symposium
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
Ross M. Maltz, MD
Melissa Kirkpatrick, PharmD, BCACP
Pathogenesis of IBD
Michele Rubin, APN, CNS, CGRN
Medical Therapies in IBD: Parts 1 & 2
Jenny S. Sauk, MD
Panel Discussion - Collins, Ferrari
Angelina Collins, MSN, ANP-BC
Melissa J. Ferrari, PA-C, MPAS
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
Ryan W. Stidham, MD, MSc
Siddharth Singh, MD
Scripps Conference: New Advances in Inflammatory Bowel Disease
Artificial Intelligence Applications in IBD 2023
Panel Discussion- Cohen, Dubinsky, Santillan
Benjamin L. Cohen, MD
Marla C Dubinsky, MD
Cynthia Santillan, MD
AGA Guidelines for Managment of Pouchitis and Inflammatory Pouch Disorders
Gaurav Syal, MD, MHDS
Case Presentation: Inpatient IBD – My Approach to Management of Intra-Abdominal Abscesses
Preventive Health in IBD
IBD 101
Suresh Pola, MD
Health Disparities in IBD
Leybelis Padilla
Panel Discussion - Ally, Boland, Syal
Mazer Ally, MD, FAGA, FACG
Brigid S. Boland, MD
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.